LOS ANGELES , June 16, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

CYBR outpaces rivals with AI-driven identity security tools, bold acquisitions, and rising subscription growth.

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Fortrea Holdings Inc. (NASDAQ:FTRE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortrea-holdings-inc-lawsuit-submission-form?prid=153315&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.

LOS ANGELES , June 16, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the federal securities laws. Shareholders who purchased the Company's securities between October 31, 2024 and April 30, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 22, 2025.

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=153317&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

CGDV is an actively managed U.S. large-cap equity fund with a slight dividend and value tilt. The fund has outperformed the S&P 500 since inception, and reasonably consistently so. Overall, CGDV is a buy due to its cost-effectiveness, marginally higher yield, and consistent outperformance.

Douglas Elliman (DOUG) is making progress with its turnaround, but recent takeover talk has been the main driver of price action lately. Although little has come out about the alleged offer, which came from a larger competitor, other strategic buyers may be interested in making a "bolt on" acquisition of Douglas Elliman. Furthermore, even if the company rebuffs any takeover offer, the company's turnaround could continue, even if the residential real estate market stays sluggish.

Air Lease CEO John Plueger joins CNBC's Phil LeBeau at the Paris Air Show to discuss the aviation demand environment, challenges at Boeing and U.S. tariffs.

RBLX delivers superior growth fundamentals compared to Take-Two. The platform's 29% revenue expansion and creator economy provide stronger investment appeal.

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Bitfarms Ltd. ("Bitfarms" or the "Company") (NASDAQ:BITF) and certain officers.

VANCOUVER, British Columbia, June 16, 2025 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) is pleased to announce the publication of its 2024 Sustainability Report which provides an overview of the Company's performance in the areas of environmental responsibility, health and safety, social engagement, and corporate governance in alignment with GRI standards and the recommendations of the TCFD and the TNFD.

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Civitas Resources, Inc. ("Civitas" or the "Company") (NYSE:CIVI) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv- 03791, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Civitas securities between February 27, 2024 and February 24, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations …

LIMASSOL, Cyprus, June 16, 2025 (GLOBE NEWSWIRE) -- Robin Energy Ltd. (NASDAQ:RBNE) ("Robin Energy" or the "Company"), an international ship-owning company providing energy transportation services globally, today announced that it has entered into a securities purchase agreement with several institutional investors to purchase 965,000 common shares at an offering price of $5.25, for gross proceeds of approximately $5.1 million (the “Offering”), before deducting commissions and offering expenses, in a registered direct offering priced at-the-market under Nasdaq rules.

With yet another war in the Middle East, defense stocks could rise significantly.

ORCL's Q4 AI growth is impressive but premium valuation suggests holding existing positions while new investors await better fiscal 2026 entry points.

I'm initiating Tonix Pharmaceuticals Holding Corp. with a Buy rating, eyeing a rally on potential FDA approval for flagship drug Tonmya in August. Tonmya targets fibromyalgia, a large, underserved market; FDA decision is due August 15th, and approval could dramatically boost Tonix's revenue. Tonix has its work cut out for it, but I'm a firm believer that they could have a first-mover advantage in this market.

To find the next 10-bagger, focus on small, profitable companies with 20%+ revenue growth, fair valuations, and long runways for reinvestment. Canadian compounders like VitalHub, Propel Holdings, Enterprise Group, and Zedcor exhibit these traits and are our highest conviction long-term investments. Patience is key; exponential returns are back-end loaded, and even after big moves, these stocks can still offer significant upside.

INmune Bio offers a high-risk, high-reward opportunity ahead of its Phase 2 Alzheimer's readout. Lead asset XPro1595's mechanism of selectively targeting soluble TNF (sTNF) has strong preclinical, mechanistic, and limited but encouraging Phase 1b data. If XPro1595 delivers positive results, it could validate a new approach in Alzheimer's and other inflammatory diseases, but the investment remains speculative due to clinical and market risks.

PITTSBURGH--(BUSINESS WIRE)--PPG showcases innovations in paints, coatings and specialty products that enhance customer productivity and accelerate organic growth.

CNBC's David Faber reports on news regarding WhatsApp.